Snail and Slug mediate tamoxifen resistance in breast cancer cells through activation of EGFR–ERK independent of epithelial–mesenchymal transition

Abstract excerpt

These authors contributed equally to this work. These authors contributed equally to this work. Dear Editor, Breast cancer is the second most common type of cancer and the leading cause of cancer death in women worldwide. Adjuvant tamoxifen therapy significantly slows down estrogen receptor (ER)-positive breast cancer progression, prolongs disease-free survival, and contributes to the decrease in breast cancer...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Cells and Metastasis
• Share to Cancer, Stress, Anesthesia, and Immune Response
• Share to Prostate Cancer Treatment and Research